2.6 Prophylactic, Empiric, & Therapeutic Antimicrobial Use

CBIC Associate Infection Prevention and Control a-IPC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 About the CBIC a-IPC Certification 1.2 Exam Format, Scoring, & Logistics 1.3 Effective Study Strategies & Preparation Plan

2 Chapter 2: Processes to Identify Infectious Diseases

2.1 Chain of Infection & Pathogen Characteristics 2.2 Diagnostic & Laboratory Testing in IPC 2.3 Identifying Healthcare-Associated Infection Syndromes 2.4 Specimen Collection, Handling, Storage, & Transport 2.5 Colonization, Infection, Contamination, & Pseudo-Infection 2.6 Prophylactic, Empiric, & Therapeutic Antimicrobial Use 2.7 Host Risk Factors & Emerging Infectious Disease Threats

3 Chapter 3: Surveillance and Epidemiologic Investigation

3.1 Surveillance Methods & Program Design 3.2 Epidemiological Calculations & Rate Metrics 3.3 Outbreak Investigation Protocols & Epidemic Curves 3.4 NHSN Definitions & Standardized Infection Ratios (SIR) 3.5 Descriptive Statistics & Presenting Surveillance Data 3.6 Surveillance Across the Care Continuum 3.7 Notifiable Disease Reporting, Data Sources, & Registries 3.8 Data Validation & Surveillance Program Evaluation 3.9 Outbreak Control Measures, Environmental Sampling, & Reporting

4 Chapter 4: Preventing and Controlling Transmission

4.1 Standard Precautions & Hand Hygiene Guidelines 4.2 Transmission-Based Precautions & Isolation Protocols 4.3 PPE Selection, Donning, Doffing, & Safety 4.4 Safe Injection Practices & Medication Preparation 4.5 Patient-Care Equipment & Point-of-Care Device Handling 4.6 Emergency Preparedness & the Infection Preventionist's Disaster Role 4.7 Bioterrorism, Special Pathogens, & Community Response Planning

5 Chapter 5: Environment of Care

5.1 Environmental Cleaning & Surface Disinfection 5.2 Water Utilities, Air Handling, & Building Systems 5.3 Construction, Renovation, & Infection Control Risk Assessment (ICRA) 5.4 Laundry, Linen, Waste Management, & Food Safety 5.5 Product Recalls, Supply Chain Monitoring, & Device Incident Reporting

6 Chapter 6: Cleaning, Disinfection, and Sterilization of Medical Devices

6.1 Spaulding Classification System 6.2 Reprocessing Steps & High-Level Disinfection (HLD) 6.3 Sterilization Methods, Monitoring, & Quality Assurance 6.4 Single-Use Devices, Outsourced Reprocessing, & IFU Review 6.5 Reprocessing Failure Investigation & Patient Notification

7 Chapter 7: Employee and Occupational Health

7.1 Occupational Exposures & Post-Exposure Prophylaxis 7.2 Healthcare Personnel Immunizations & Screening 7.3 Work Restrictions & Fit-for-Duty Evaluations 7.4 Sharps Injury Prevention, Product Sensitivities, & Alternatives

8 Chapter 8: Management, Communication, and Antimicrobial Stewardship

8.1 IPC Program Governance, Policies, & Accreditation 8.2 Interdisciplinary Collaboration & Crisis Communication 8.3 Antimicrobial Stewardship Principles & Interventions 8.4 Chain of Command, Resource Advocacy, & the Business Case

9 Chapter 9: Education, Research, and Performance Improvement

9.1 Adult Learning Principles & Staff Education 9.2 Quality Improvement Models & Implementation Science 9.3 Critical Appraisal of Infection Prevention Literature

2.6 Prophylactic, Empiric, & Therapeutic Antimicrobial Use

Key Takeaways Explain This Topic AI

Prophylactic antimicrobials prevent an infection that has not occurred, empiric therapy treats a suspected infection before the organism is known, and therapeutic (definitive) therapy is directed by culture and susceptibility results.

Surgical antimicrobial prophylaxis should be infused within 60 minutes before incision, or within 120 minutes for vancomycin and fluoroquinolones, which require longer infusion times.

Guidelines call for discontinuing surgical prophylaxis at the end of the procedure; continuing it beyond 24 hours does not lower surgical site infection rates and increases resistance and Clostridioides difficile risk.

An antibiotic time-out at 48 to 72 hours is the point at which empiric therapy should be reassessed and de-escalated to definitive therapy.

Diagnostic stewardship controls which tests are ordered and on whom, preventing colonization from being detected, reported, and then unnecessarily treated.

Last updated: August 2026

2.6 Prophylactic, Empiric, & Therapeutic Antimicrobial Use

Quick Answer: Prophylactic = given to a patient without infection to prevent one (surgical prophylaxis, post-exposure prophylaxis). Empiric = given for a suspected infection before the pathogen is identified, guided by syndrome, severity, and the local antibiogram. Therapeutic (definitive/directed) = given after culture and susceptibility results, narrowed to the smallest effective spectrum.

The 2025 outline places this task in Domain 1 rather than in the stewardship domain, and the reason is diagnostic: an IP who cannot tell which category a patient's antibiotics belong to cannot tell whether the antibiotics are appropriate, cannot interpret an antibiogram, and cannot recognize when a colonization result has been mistaken for infection.

The Three Categories

Loading diagram...

1. Prophylactic

Given to a patient who is not infected, to prevent infection from a defined, anticipated exposure or breach.

Surgical antimicrobial prophylaxis — the highest-yield example

Post-exposure prophylaxis (PEP) after a bloodborne pathogen exposure, meningococcal exposure, or rabies exposure

Primary prophylaxis in immunocompromised hosts — for example, trimethoprim-sulfamethoxazole against Pneumocystis jirovecii

• Peri-procedural prophylaxis before invasive urologic procedures in a patient with known bacteriuria
• 2. Empiric

Started after cultures are drawn but before results return, when delaying therapy is dangerous. Empiric selection is driven by:

• The clinical syndrome and its likely pathogens
• Severity — septic shock justifies broader initial coverage than uncomplicated cystitis
• The local antibiogram and unit-level resistance patterns

Patient-specific risk : prior MDRO colonization, recent antimicrobial exposure, healthcare contact, allergies, renal function

3. Therapeutic (definitive/directed)

Once the organism and its susceptibilities are known, therapy is de-escalated to the narrowest effective agent, with a defined stop date. De-escalation is one of the two highest-impact stewardship interventions, and it is why drawing cultures before the first dose matters so much: a culture-negative patient cannot be de-escalated with confidence and often stays on broad therapy for the full course.

Surgical Antimicrobial Prophylaxis in Detail

Surgical prophylaxis appears repeatedly on the exam because it is measurable, protocolized, and frequently done wrong.

Element Standard

Agent Usually cefazolin ; add or substitute per procedure and patient factors (e.g., add anaerobic coverage for colorectal surgery)

• Timing Infusion complete within 60 minutes before incision
• Timing exception Within 120 minutes for vancomycin and fluoroquinolones , which require prolonged infusion
• Dose Weight-based — under-dosing obese patients is a common failure

Redosing Intraoperatively for procedures exceeding two half-lives of the agent (cefazolin roughly every 4 hours) or with major blood loss

Duration Discontinue at the end of the procedure for most operations; there is no benefit beyond 24 hours

Exam Tip: If a stem describes prophylactic antibiotics continued for three postoperative days "to be safe," the correct answer involves stopping them . Prolonged prophylaxis does not reduce surgical site infection and measurably increases C. difficile infection, acute kidney injury, and resistance.

Other prophylaxis failure modes an IP audits: administering the dose in the pre-op holding area two hours before an unexpectedly delayed incision, forgetting the intraoperative redose in a long case, and using vancomycin routinely rather than reserving it for documented beta-lactam allergy or known MRSA colonization.

The Antibiotic Time-Out

The antibiotic time-out at 48–72 hours is the structured pause where the team asks:

Does the patient actually have an infection?

What do the cultures show?

Can therapy be narrowed or stopped ?

Can the route be changed from IV to oral ?

What is the stop date ?

This is the operational bridge between empiric and therapeutic use, and it is a named element of CDC's Core Elements of Hospital Antibiotic Stewardship Programs.

Diagnostic Stewardship: Controlling the Upstream Trigger

The 2025 outline pairs stewardship with identification for a reason. Diagnostic stewardship means ordering the right test, on the right patient, at the right time — because a test that should never have been ordered generates a result that drives treatment that was never needed.

• Intervention What it prevents
• Reflex urine culture only when urinalysis shows pyuria Treating asymptomatic bacteriuria

Hard stop on C. difficile testing for formed stool or patients on laxatives within 48 h Converting colonization into reported infection

• Restricting repeat blood cultures within 24 h without new clinical change Chasing contaminants
• Discouraging "pan-culture" order sets for isolated fever Wide-net testing that finds colonizers

Avoiding surveillance cultures of wounds and tracheostomy sites without clinical indication Treating airway and wound colonization

Diagnostic stewardship also protects surveillance validity . Facilities that test more find more, and an SIR that rises because testing practices changed rather than because care worsened will send an IPC program chasing the wrong problem entirely.